Myriad Genetics Inc. (MYGN) Financial Statements (2025 and earlier)

Company Profile

Business Address 322 NORTH 2200 WEST
SALT LAKE CITY, UT 84116
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
6/30/2020
6/30/2019
6/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:140,900169,700398,800217,800136,900180,600
Cash and cash equivalents132,10056,900258,400163,70093,200110,900
Short-term investments 8,80058,00081,40054,10043,70069,700
Other undisclosed cash, cash equivalents, and short-term investments  54,80059,000   
Restricted cash and investments 1,200     
Receivables114,300101,60091,30071,000138,600102,100
Inventory, net of allowances, customer advances and progress billings22,00020,10015,30029,10031,40034,300
Inventory22,00020,10015,30029,10031,40034,300
Prepaid expense17,00017,60018,400 25,100 
Other undisclosed current assets18,200(34,400)(39,000)13,80016,6009,400
Total current assets:313,600274,600484,800331,700348,600326,400
Noncurrent Assets
Operating lease, right-of-use asset61,600103,90081,80066,000
Property, plant and equipment119,00083,40043,50037,00057,30043,200
Long-term investments and receivables  54,80059,00037,00054,90030,700
Long-term investments  54,80059,00037,00054,90030,700
Intangible assets, net (including goodwill)636,900666,500643,300932,9001,101,900773,800
Goodwill287,400286,800239,200327,600417,200318,600
Intangible assets, net (excluding goodwill)349,500379,700404,100605,300684,700455,200
Other noncurrent assets15,40015,5008,300   
Total noncurrent assets:832,900924,100835,9001,072,9001,214,100847,700
TOTAL ASSETS:1,146,5001,198,7001,320,7001,404,6001,562,7001,174,100
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities139,700123,100186,10097,600112,20094,300
Accounts payable25,80028,80029,60021,70033,30026,000
Accrued liabilities113,90094,300156,50075,90078,90068,300
Deferred revenue 500 5,20032,800
Business combination, contingent consideration, liability    3,1003,4005,300
Contract with customer, liability2,200
Other undisclosed current liabilities15,70014,10013,00013,500 2,600
Total current liabilities:155,900137,200204,300147,000117,800102,200
Noncurrent Liabilities
Long-term debt and lease obligation38,500 79,300281,300233,5009,300
Long-term debt, excluding current maturities38,500  224,400233,5009,300
Liabilities, other than long-term debt, including:138,700148,90041,40034,6007,8006,300
Deferred tax liabilities, net82,60057,300
Deferred income tax liabilities  3,50035,80026,600
Other liabilities41,30014,5005,6004,3007,8006,300
Operating lease, liability97,400130,90079,30056,900
Business combination, contingent consideration, liability    3,70010,4009,200
Other undisclosed liabilities, other than long-term debt     (93,000)(66,500)
Other undisclosed noncurrent liabilities30,20026,80027,90023,500114,70091,400
Total noncurrent liabilities:207,400175,700148,600339,400356,000107,000
Total liabilities:363,300312,900352,900486,400473,800209,200
Equity
Equity, attributable to parent783,200885,800967,800918,2001,088,900964,900
Common stock900800800700700700
Additional paid in capital1,415,5001,260,1001,226,3001,096,6001,068,000915,400
Accumulated other comprehensive loss(3,700)(8,900)(5,100)(5,200)(5,400)(4,100)
Retained earnings (accumulated deficit)(629,500)(366,200)(254,200)(173,900)25,60052,900
Total equity:783,200885,800967,800918,2001,088,900964,900
TOTAL LIABILITIES AND EQUITY:1,146,5001,198,7001,320,7001,404,6001,562,7001,174,100

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
6/30/2020
6/30/2019
6/30/2018
Revenues753,200678,400690,600638,600851,100772,600
Cost of revenue(166,600)(149,300)(296,800)(111,300)(130,000)(29,500)
Cost of goods and services sold  (11,700)   
Gross profit:586,600529,100393,800527,300721,100743,100
Operating expenses(844,000)(669,700)(584,300)(759,000)(713,500)(624,400)
Operating income (loss):(257,400)(140,600)(190,500)(231,700)7,600118,700
Nonoperating income (expense)(4,800)3,200133,4008,400(7,600)(1,800)
Investment income, nonoperating2,5002,6007003,0003,2001,800
Other nonoperating income (expense)(4,400)600139,30016,2001,200(400)
Interest and debt expense(2,900)(3,200)(6,600)(10,800)(12,000)(3,200)
Income (loss) from continuing operations before equity method investments, income taxes:(265,100)(140,600)(63,700)(234,100)(12,000)113,700
Other undisclosed income from continuing operations before income taxes2,900 6,60010,800 3,200
Income (loss) from continuing operations before income taxes:(262,200)(140,600)(57,100)(223,300)(12,000)116,900
Income tax expense (benefit)(1,100)28,60029,90023,7004,40014,000
Income (loss) from continuing operations:(263,300)(112,000)(27,200)(199,600)(7,600)130,900
Income (loss) before gain (loss) on sale of properties:(27,200)(199,600)(7,600)130,900
Other undisclosed net income     12,000 
Net income (loss):(263,300)(112,000)(27,200)(199,600)4,400130,900
Net income attributable to noncontrolling interest    100200200
Net income (loss) available to common stockholders, diluted:(263,300)(112,000)(27,200)(199,500)4,600131,100

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
6/30/2020
6/30/2019
6/30/2018
Net income (loss):(263,300)(112,000)(27,200)(199,600)4,400130,900
Comprehensive income (loss):(263,300)(112,000)(27,200)(199,600)4,400130,900
Comprehensive income, net of tax, attributable to noncontrolling interest    100200200
Other undisclosed comprehensive income (loss), net of tax, attributable to parent5,200(3,800)(2,800)100(1,300)1,500
Comprehensive income (loss), net of tax, attributable to parent:(258,100)(115,800)(30,000)(199,400)3,300132,600

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: